Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
alpha-Fetoprotein/AFP Antibody (C2) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP2480160.2MG
Description
alpha-Fetoprotein/AFP Monoclonal antibody specifically detects Antigen in Bovine (Negative), Canine (Negative), Human, Mouse, Rat (Negative) samples. It is validated for Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin).Specifications
alpha-Fetoprotein/AFP | |
Monoclonal | |
1.0 mg/mL | |
Flow Cytometry : 0.5 - 1 ug/million cells in 0.1 ml, Immunohistochemistry-Paraffin : 1 - 2 ug/ml, Immunofluorescence : 0.5 - 1.0 ug/ml, CyTOF-ready | |
Alpha-1-fetoprotein, Alpha-fetoglobulin, alpha-fetoprotein, FETA, HP, HPAFP | |
Mouse | |
70 kDa | |
0.2 mg | |
Cancer, Cancer Stem Cells, GPCR, Stem Cell Markers, Tumor Biomarkers | |
174 | |
Human, Mouse, Bovine (Negative), Canine (Negative), Rat (Negative) | |
Purified |
Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence, CyTOF | |
C2 | |
Unconjugated | |
PBS with No Preservative | |
AFP | |
Alpha fetoprotein (AFP) purified from serum of a hepatoma patient. | |
Protein A or G purified | |
RUO | |
Primary | |
It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP) (ISOBM TD-2 workshop). This MAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. AFP is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. Antibody to AFP has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction